Biotechnology
Acorda
Therapies
Neurological
United
States
Finland
Acquisition
M&A Advisory
Lazard
Full Credential Description
Acorda Therapeutics. Finland, United States. Announced Date 19/01/2016. Closed Date 30/09/2016. Deal value: $363m. Acorda to acquire Biotie Therapies. Industry: Acorda Therapeutics is a biotechnology company focused on developing therapies for neurological disorders.